Program Director, SBIR/STTR, Biological Technologies
National Science Foundation, Virginia, United States
Erik Pierstorff joined the NSF as Program Director in November 2019. Prior to NSF, he was Chief of Operations and led Research and Development at O-Ray Pharma, where he focused on integrating biology and biomedical engineering for the goal of drug development and sustained drug delivery for the treatment of hearing loss and other ear disorders. During his time working at early stage companies, he helped secure both Angel investment and non-dilutive funding in the form of licensing and co-development deals. Additionally, he served as Principal Investigator on several Phase I, II and IIB SBIR grants from the National Institutes of Health and NSF. His research interests have focused on the intersection of the biotic and abiotic, spanning molecular and cell biology, materials science, gene therapy, nanomaterials and drug delivery. Erik has a Ph.D. in Molecular and Cell Biology from the University of California, Berkeley, and a B.S. in Biology from Emory University.
Disclosure information not submitted.
Wednesday, February 9, 2022
11:30 AM – 12:00 PM